Manmeet S. Ahluwalia, MD, MBA, FASCO
Fernandez Family Foundation Endowed Chair in Cancer Research
Chief of Medical Oncology,
Chief Scientific Officer & Deputy Director
Miami Cancer Institute
Baptist Health South Florida
Professor of Translational Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, FL
Manmeet Ahluwalia, MD is the Chief Scientific Officer, Chief of Medical Oncology, and the Deputy Director of the Miami Cancer Institute (MCI). Prior to his current role, Dr. Ahluwalia served as an endowed professor and physician-scientist at the Cleveland Clinic, where he built a world-class brain tumors clinical trials program. He led several landmark clinical trials in neuro-oncology resulting in over 250 publications. Currently, he is an NIH R01 grant-funded investigator on AI-based radiomics in glioblastoma (3.9 million USD). He serves as a clinical trial leader on an NIH PO1 grant of over 10 million USD focused on gender-specific differences in GBM.
Dr. Ahluwalia has been a leader in organized efforts in oncology. He currently serves as the chair of the US National Cancer Institute (NCI) South-West Oncology Group (SWOG) Brain Tumor Working Group and co-chair of the Diversity, Equity, and Inclusion Committee of SWOG. He also chairs the Scientific Review Committee of the International Gamma Knife Research Foundation. He also serves as a member of the National Brain Tumor Society (NBTS) Roundtable Committee and as founder PI of the coordinating site for the International Radiosurgery Research Foundation.
He is the recipient of several prestigious awards including the Fellowship of the American Society of Clinical Oncology (ASCO), the National Cancer Institute/CTEP Career Development Award via the American Brain Tumor Consortium (ABTC), ASCO Leadership Development Program and the American Association of Physicians of Indian Origin Most Distinguished Physician award.
